Curaleaf Holdings (CURLF) Cost of Revenue (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly Cost of Revenue of $166.9 million in Q1 2026, up 97370.7% quarter-over-quarter from $171273.0 in Q4 2025, and up 10.51% on a YoY basis from $151.1 million in Q1 2025.
Curaleaf Holdings (CURLF) Cost of Revenue (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Cost of Revenue history runs 8 years deep, the most recent figure standing at $166.9 million for Q1 2026.
- In Q1 2026, Cost of Revenue rose 10.51% year-over-year to $166.9 million; the TTM figure through Mar 2026 stood at $327.8 million (down 50.82% YoY), while the FY2025 annual figure was $637.1 million, down 8.13% from the prior year.
- Cost of Revenue was $166.9 million for Q1 2026 at Curaleaf Holdings, up from $171273.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $274.4 million in Q4 2022 to a low of $161967.0 in Q2 2025.
- Historically, Cost of Revenue has averaged $142.6 million across 5 years, with a median of $162.1 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Cost of Revenue slumped 99.93% in 2023, then soared 86456.8% in 2024.
- A 5-year view of Cost of Revenue shows it stood at $274.4 million in 2022, then plunged by 99.93% to $189077.0 in 2023, then jumped by 86456.8% to $163.7 million in 2024, then slumped by 99.9% to $171273.0 in 2025, then surged by 97370.7% to $166.9 million in 2026.
- The last three Cost of Revenue figures came in at $166.9 million (Q1 2026), $171273.0 (Q4 2025), and $160.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | 166.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 166.94 Mn |
| Mar 31, 2026 | 166.94 Mn |
| Dec 31, 2025 | 171,273.00 |
| Dec 31, 2025 | 171,273.00 |
| Sep 30, 2025 | 160.50 Mn |
| Sep 30, 2025 | 160.50 Mn |
| Jun 30, 2025 | 161,967.00 |
| Jun 30, 2025 | 161,967.00 |
| Mar 31, 2025 | 151.06 Mn |
| Mar 31, 2025 | 151.06 Mn |
| Dec 31, 2024 | 163.66 Mn |
| Dec 31, 2024 | 163.66 Mn |
| Sep 30, 2024 | 170.01 Mn |
| Sep 30, 2024 | 170.01 Mn |
| Jun 30, 2024 | 181.82 Mn |
| Jun 30, 2024 | 181.82 Mn |
| Mar 31, 2024 | 178.03 Mn |
| Mar 31, 2024 | 178.03 Mn |
| Dec 31, 2023 | 189,077.00 |
| Dec 31, 2023 | 189,077.00 |